BEYOND DRUG PRICING REFORM: WHY PAYMENT PREVENTION REMAINS MEDICAID’S GREATEST SAVINGS OPPORTUNITY

Drug pricing reform remains a central focus of Medicaid cost-containment discussions as policymakers, regulators, and state agencies search for ways to lower pharmaceutical spending and improve long-term program sustainability. Initiatives such as CMS’s GENEROUS Model reflect growing interest in leveraging purchasing power, supplemental rebates, and alternative payment approaches to reduce prescription drug expenditures.

While these efforts may generate meaningful savings, they do not address one of Medicaid’s most persistent financial challenges: improper payments driven by incomplete eligibility information, unidentified commercial coverage, incomplete third-party liability (TPL) records, and coordination of benefits (COB) failures.

Reducing the cost of healthcare services is important. Ensuring Medicaid pays the right claims is equally important.

MEDICAID’S GREATEST FINANCIAL LEAKAGE OCCURS BEFORE RECOVERY BEGINS

When an improper payment is identified, the conversation typically shifts to recovery.

Can the funds be recouped? Can another payer be billed? Can the overpayment be corrected?

These are important questions, but they address a problem only after the payment has already occurred.

By that point, administrative resources have been consumed, recovery efforts have begun, and the original payment error has already impacted program integrity performance.

Recovery has value. Every dollar returned to Medicaid matters. However, recovery is not the same as prevention.

Recovering an improper payment does not change the fact that the payment occurred, nor does it eliminate the operational burden created by the error. Most importantly, it does not change the original adjudication decision that allowed the claim to be paid incorrectly.

The most effective program integrity strategy is preventing improper payments before they occur.

THE LACK OF QUALITY ELIGIBILITY DATA AND UNKNOWN TPL

One of the largest drivers of Medicaid payment errors is not fraud. It is missing information.

Medicaid operates in a constantly changing eligibility environment. Beneficiaries gain employer-sponsored insurance, lose commercial coverage, add dependents, switch plans, move between programs, and experience life events that affect insurance status throughout the year. The challenge is that Medicaid systems often do not see those changes immediately.

Commercial coverage can become active before it appears in eligibility files. Third-party liability information may be incomplete or outdated. Provider-identified coverage may never reach broader Medicaid systems. Carrier reporting delays can create visibility gaps that last for weeks or even months.

When claims are adjudicated during those gaps, Medicaid may pay as the primary payer when another insurer should have paid first. Those payments are entirely preventable if the coverage is known. Unfortunately, unknown coverage remains one of Medicaid’s biggest blind spots.

YOU CAN’T COORDINATE BENEFITS YOU CAN’T SEE

Coordination of benefits is only as effective as the information supporting it.

If commercial insurance is not identified, Medicaid cannot determine the correct payer order. If eligibility records are outdated, claims decisions are based on incomplete information. If TPL data is missing, cost-avoidance opportunities disappear before adjudication even begins.

This is why unknown commercial coverage sits at the center of so many improper payment challenges.

The issue is not a lack of coordination. The issue is a lack of visibility.

Without accurate and timely coverage information, even the most sophisticated coordination-of-benefits processes cannot function as intended.

PREVENTION SUPPORTS PAYMENT ACCURACY

Drug pricing initiatives are designed to reduce the cost of healthcare services. Payment prevention focuses on ensuring claims are paid correctly. The distinction matters because payment accuracy is increasingly important to Medicaid program integrity efforts.

Federal payment accuracy measurements evaluate whether claims were processed correctly based on the information available at the time of adjudication. If commercial coverage is identified after payment, the original error still occurred. If eligibility information is outdated when a claim is processed, recovery efforts do not erase the initial mistake.

Improving payment accuracy requires improving the quality, completeness, and timeliness of the information available before payment decisions are made. The earlier coverage is identified, the greater the opportunity to prevent improper payments before they occur.

MEDICAID’S MOST IMMEDIATE SAVINGS OPPORTUNITY

Many healthcare reforms require years to implement and evaluate. Payment prevention offers something different. The technology exists today. The data exists today. The operational strategies exist today.

Medicaid agencies and managed care organizations can improve eligibility verification, strengthen TPL identification efforts, increase visibility into commercial coverage, and enhance coordination of benefits operations without waiting for future legislation or regulatory changes.

The savings are measurable. The impact is immediate. And the benefits extend across every area of program integrity.

Drug pricing reform and payment prevention should be viewed as complementary strategies, not competing priorities. Lower healthcare costs help control spending. Payment prevention helps ensure Medicaid pays only when it is the appropriate payer. Medicaid agencies and managed care organizations that improve eligibility visibility, strengthen TPL identification, and prevent improper payments before they occur will be best positioned to achieve sustainable savings and stronger program integrity outcomes.

Click here to read more.

SyrtisSolutions #Medicaid #DrugPricingReform #CostAvoidance